Culligan signs Turkmenistan deal

• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 127 KB
• Volume: 1998
• Category: Article
• ISSN: 1365-6937
• DOI: 10.1016/s1365-6937(98)90342-2

✦ Synopsis

receiving net proceeds of US$33 480 000. V1TEX is a leading developer of a broad portfolio of blood products and systems using its proprietary viral inactivation technologies. VITEX's technologies are intended to address the risk of viral contamination in blood products, including plasma, plasma derivatives, red blood cells and platelets.

US FILTER COMPLETES ACQUISITION OF CULLIGAN US Filter Corporation has completed the acquisition of Culligan Water Technologies

Inc. The acquisition of Culligan, a Northbrook, Illinois-based manufacturer and distributor of water purification and treatment products, was approved by Culligan stockholders and US Filter